CDKN2A Gene Mutations
Information for People with an Inherited CDKN2A Mutation
What are the cancer risks for people with a CDKN2A mutation?
People with an in CDKN2A have Familial Atypical Multiple Mole Melanoma (FAMMM) syndrome. This mutation increases the risk for pancreatic cancer and melanoma.
What can people with a CDKN2A mutation do?
Experts have created guidelines which estimate cancer risks and outline recommendations for managing these risks in people with a CDKN2A mutation.
There may be family planning concerns and options for people with an inherited CDKN2A mutation.
Each of these topics is outlined in more detail in the sections highlighted below.
In the News
More Information on CDKN2A Mutations
Cancer Risks
Cancer risk estimates are updated based on the latest research. Read about the lifetime risk for different cancers in people with inherited CDKN2A mutations.
Risk Management Options
Read about the latest expert guidelines for cancer screening and prevention for people with a CDKN2A mutation. Learn about research studies enrolling high-risk patients.
Cancer Treatment Options
Tumor testing and genetic testing can provide additional clues about which treatments may work best for your cancer. People who test positive for a CDKN2A mutation may have additional treatment or clinical trial options available to them.
Other Considerations
Learn additional information about inherited CDKN2A mutations and options related to family planning.
More Resources
Participate in Research
The studies below are enrolling people with CDKN2A mutations. To search for more studies, visit our Search and Enroll Tool.
Pancreatic Cancer Early Detection for People at High Risk
Clinicaltrials.gov identifier:
NCT04970056
Testing a Vaccine for Cancer Prevention in People with a BRCA1 or BRCA2 Mutation
Clinicaltrials.gov identifier:
NCT04367675
